annb0t
Top 20
For the quarter ended September 2023, ResMed (RMD) reported revenue of $1.1 billion, up 16% over the same period last year. EPS came in at $1.64, compared to $1.51 in the year-ago quarter.
The reported revenue represents a surprise of +0.51% over the Zacks Consensus Estimate of $1.1 billion. With the consensus EPS estimate being $1.63, the EPS surprise was +0.61%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St...
>>> Read more: ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The reported revenue represents a surprise of +0.51% over the Zacks Consensus Estimate of $1.1 billion. With the consensus EPS estimate being $1.63, the EPS surprise was +0.61%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St...
>>> Read more: ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
